anonymous
Guest
anonymous
Guest
The price seems stretched a little too thin.
Where is a safe place for our 401k money?
Don't get me wrong. I am not a doomer. For sure, amazing growth potential and value can be found with anti-obesity injectables, which translates into better health outcomes for all. But are we the best company to scale this up? Will Eli Lilly be an heroic household name among tens of millions of homes nationwide and globally? Can supply chain and manufacturing challenges be overcome? Can the cost of the therapies find a "goldlilocks" zone of attractive price, yet agreeable profitable?
Where is a safe place for our 401k money?
Don't get me wrong. I am not a doomer. For sure, amazing growth potential and value can be found with anti-obesity injectables, which translates into better health outcomes for all. But are we the best company to scale this up? Will Eli Lilly be an heroic household name among tens of millions of homes nationwide and globally? Can supply chain and manufacturing challenges be overcome? Can the cost of the therapies find a "goldlilocks" zone of attractive price, yet agreeable profitable?